Warner, S.; Blaxland, A.; Counoupas, C.; Verstraete, J.; Zampoli, M.; Marais, B.J.; Fitzgerald, D.A.; Robinson, P.D.; Triccas, J.A.
Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis? Vaccines 2023, 11, 1313.
https://doi.org/10.3390/vaccines11081313
AMA Style
Warner S, Blaxland A, Counoupas C, Verstraete J, Zampoli M, Marais BJ, Fitzgerald DA, Robinson PD, Triccas JA.
Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis? Vaccines. 2023; 11(8):1313.
https://doi.org/10.3390/vaccines11081313
Chicago/Turabian Style
Warner, Sherridan, Anneliese Blaxland, Claudio Counoupas, Janine Verstraete, Marco Zampoli, Ben J. Marais, Dominic A. Fitzgerald, Paul D. Robinson, and James A. Triccas.
2023. "Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis?" Vaccines 11, no. 8: 1313.
https://doi.org/10.3390/vaccines11081313
APA Style
Warner, S., Blaxland, A., Counoupas, C., Verstraete, J., Zampoli, M., Marais, B. J., Fitzgerald, D. A., Robinson, P. D., & Triccas, J. A.
(2023). Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis? Vaccines, 11(8), 1313.
https://doi.org/10.3390/vaccines11081313